Cambridge, UK, 1 March 2017 – Napp Pharmaceuticals Ltd is excited to announce the appointment of Hywel Day as the new Managing Director of Napp Pharmaceuticals. In his new role, Hywel will build on Napp’s success as an effective Partnership Selling Organisation, demonstrating that partnering with Napp is truly “the way to market” for the NHS, customers and potential business partners.
Hywel joins Napp from Mundipharma BV in the Netherlands where he was General Manager. In his previous role, Hywel successfully led the business through a substantial transformation, which involved a significant cultural shift and a diversification of the business portfolio. His appointment marks a return to Napp where he previously held roles of increasing seniority, including the leadership post of UK Sales Director. He has a long and successful history of working within the pharmaceutical industry, having started his career more than 20 years ago as a sales representative.
Commenting on his appointment, Hywel said, “to be given the opportunity to lead a top UK pharmaceutical company is incredibly exciting. Not only is Napp a company with a long heritage of providing innovative, high-quality medicines to patients, but it is also a great place to work. I’m looking forward to working with a great bunch of intelligent, diligent and fun people – together, we will continue to nurture Napp’s values of striving for excellence and delivering on our promises to the NHS, patients, our business partners and each other.”
